Effects of bepotastine ophthalmic solution on ocular redness in patients with seasonal allergic rhinoconjunctivitis

Trial Profile

Effects of bepotastine ophthalmic solution on ocular redness in patients with seasonal allergic rhinoconjunctivitis

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Mar 2012

At a glance

  • Drugs Bepotastine (Primary)
  • Indications Allergic rhinoconjunctivitis
  • Focus Therapeutic Use
  • Sponsors ISTA Pharmaceuticals
  • Most Recent Events

    • 09 Mar 2012 New trial record
    • 06 Mar 2012 Results presented at the 68th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top